Most Read Articles
11 Aug 2020
During the Allergic Rhinitis (AR) Boot Camp held in conjunction with the Bayer Pharmacist Congress 2020, Professor Dr Baharudin Abdullah discussed the management of AR in the primary care setting and the importance of using patient profiles to guide the choice of antihistamines.
Elaine Soliven, 3 days ago
Adding mepolizumab to standard of care treatment significantly reduces nasal polyp size and obstruction in adults with chronic rhinosinusitis with nasal polyps (CRSwNP), according to the SYNAPSE* study presented at ERS 2020.
5 days ago
OZEMPIC – Semaglutide 1.34 mg/mL soln for inj
Audrey Abella, 11 Sep 2020
A prasugrel de-escalation strategy significantly reduced the risk of NACE* and bleeding events in patients with ACS** after PCI*** compared with the conventional strategy, results of the HOST-REDUCE-POLYTECH-ACS# trial have shown.

DG Speaks: NHMS 2019, the NCD war, and the roles of pharmacists

Rachel Soon
Medical Writer
28 Aug 2020
Tan Sri Dato' Seri Dr Noor Hisham Abdullah, Director-General of Health, MOH. (Photo credit: Corporate Communication Unit, MOH)

Malaysians need to start viewing non-communicable diseases (NCDs) as an emergency, says MOH Director-General of Health Tan Sri Dato' Seri Dr Noor Hisham Abdullah, in response to the recently published National Health and Morbidity Survey (NHMS 2019).

In June, among the stream of headlines covering the COVID-19 pandemic, the publication of the NHMS 2019 results made a quieter splash, revealing concerning trends in NCD prevalence among Malaysians (see infographic).

Speaking in an interview with MIMS Pharmacist, Noor Hisham noted that an estimated 91.5% of COVID-19 deaths in Malaysia were associated with at least one NCD, demonstrating the need to invest in NCD prevention and control as an essential foundation for security and preparedness.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
11 Aug 2020
During the Allergic Rhinitis (AR) Boot Camp held in conjunction with the Bayer Pharmacist Congress 2020, Professor Dr Baharudin Abdullah discussed the management of AR in the primary care setting and the importance of using patient profiles to guide the choice of antihistamines.
Elaine Soliven, 3 days ago
Adding mepolizumab to standard of care treatment significantly reduces nasal polyp size and obstruction in adults with chronic rhinosinusitis with nasal polyps (CRSwNP), according to the SYNAPSE* study presented at ERS 2020.
5 days ago
OZEMPIC – Semaglutide 1.34 mg/mL soln for inj
Audrey Abella, 11 Sep 2020
A prasugrel de-escalation strategy significantly reduced the risk of NACE* and bleeding events in patients with ACS** after PCI*** compared with the conventional strategy, results of the HOST-REDUCE-POLYTECH-ACS# trial have shown.